306 related articles for article (PubMed ID: 30871055)
1. Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.
Skarkova V; Kralova V; Vitovcova B; Rudolf E
Cells; 2019 Mar; 8(3):. PubMed ID: 30871055
[TBL] [Abstract][Full Text] [Related]
2. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
3. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
Hoshiba T
Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
[TBL] [Abstract][Full Text] [Related]
4. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
7. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α.
Zhang W; Yuan W; Song J; Wang S; Gu X
Biochimie; 2018 Jan; 144():21-27. PubMed ID: 29017924
[TBL] [Abstract][Full Text] [Related]
8. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
[TBL] [Abstract][Full Text] [Related]
10. DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance.
Wu C; Sun G; Wang F; Chen J; Zhan F; Lian X; Wang J; Weng F; Li B; Tang W; Quan J; Xiang D
Sci Rep; 2022 Dec; 12(1):22496. PubMed ID: 36577753
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.
Gurzu S; Silveanu C; Fetyko A; Butiurca V; Kovacs Z; Jung I
World J Gastroenterol; 2016 Aug; 22(30):6764-75. PubMed ID: 27570416
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells.
Skarkova V; Kralova V; Krbal L; Matouskova P; Soukup J; Rudolf E
Exp Cell Res; 2018 Aug; 369(2):295-303. PubMed ID: 29842879
[TBL] [Abstract][Full Text] [Related]
13. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
Liu X; Fu Q; Du Y; Yang Y; Cho WC
Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
[TBL] [Abstract][Full Text] [Related]
15. Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative.
Lee TY; Liu CL; Chang YC; Nieh S; Lin YS; Jao SW; Chen SF; Liu TY
Oncotarget; 2016 Apr; 7(17):23512-20. PubMed ID: 26992205
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
Cao H; Xu E; Liu H; Wan L; Lai M
Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
[TBL] [Abstract][Full Text] [Related]
17. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
18. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.
Ding J; Zhao Z; Song J; Luo B; Huang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):597-604. PubMed ID: 29701752
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the mechanism of
Gu J; Lv X; Li W; Li G; He X; Zhang Y; Shi L; Zhang X
Front Immunol; 2023; 14():1230681. PubMed ID: 37781363
[No Abstract] [Full Text] [Related]
20. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
